Serum caspase-8 levels were found to be significantly lower in women with papillary serous cystadenocarcinoma (p ˂ 0.001) and ovarian serous cystadenoma (p ˂ 0.05) compared to serum levels of this parameter in healthy women. This evidence concerns the gene CASP8 and papillary serous cystadenocarcinoma.